Cargando…
Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients
Background: Clinical significance of germinal center B-cell (GCB) and non-GCB sub-categorization, expression of MYC, BCL2, BCL6, CD5 proteins and Epstein Barr virus encoded RNA (EBER) positivity in diffuse large B-cell lymphoma (DLBCL) remain controversial. Could these biomarkers accurately identify...
Autores principales: | Ting, Choo-Yuen, Chang, Kian-Meng, Kuan, Jew-Win, Sathar, Jameela, Chew, Lee-Ping, Wong, Oy-Leng Jacqueline, Yusuf, Yusri, Wong, Lily, Samsudin, Ahmad Toha, Pana, Mohd Nurjaya Bin Mohd, Lee, Suk-Kam, Gopal, Navarasi S. Raja, Puri, Rita, Ong, Tee-Chuan, Bahari, Samsol Kamal, Goh, Ai-Sim, Teoh, Ching- Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535654/ https://www.ncbi.nlm.nih.gov/pubmed/31171907 http://dx.doi.org/10.7150/ijms.27610 |
Ejemplares similares
-
High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021) -
Expression of c-Myc, Bcl2, Bcl6, and Cyclin D1 in High-Grade B-Cell Lymphoma
por: Ali, Seemal, et al.
Publicado: (2022) -
Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6(+) germinal center B cells or Bcl6(−)Bcl2(+) non‐germinal center B cells
por: Onabajo, Olusegun O., et al.
Publicado: (2018) -
C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
por: Salam, Dayang Sharyati Datu Abdul, et al.
Publicado: (2020) -
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)